Pathalys Pharma Competitors and Similar CompaniesClear all
Lava Therapeutics's competitors and similar companies include Quellis Biosciences and Eagle Pharmaceuticals.
 Lava Therapeutics Lava Therapeutics is a biotech company that develops T-cell engagers for the therapy of solid tumors and hematologic malignancies. |  Quellis Biosciences Quellis is a biopharmaceutical company focused on discovering new molecules to treat serious rare diseases. |  Eagle Pharmaceuticals Eagle Pharmaceuticals is a specialty pharmaceutical company, focusing on developing and commercializing injectable products primarily in the critical care and oncology areas. | |
Founding Date | Founding Date 2016 | Founding Date 2017 | Founding Date 2007 |
Type | Type Public | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations Utrecht, NL HQ Philadelphia, US | Locations Boston, US HQ | Locations Woodcliff Lake, US HQ Chicago, US |
Employees | Employees 34 | Employees N/A | Employees 10813% increase |
Valuation ($) | Valuation ($) 53.4 m | Valuation ($) N/A | Valuation ($) 5.2 m |
Financial | |||
Revenue (est.) | Revenue (est.) $12m (FY, 2024) | Revenue (est.) N/A | Revenue (est.) $316.6m (FY, 2022) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $85.5m (FY, 2022) |
Gross profit | Gross profit $12m (FY, 2024) | Gross profit N/A | Gross profit $231.2m (FY, 2022) |
Net income | Net income ($25.1m) (FY, 2024) | Net income N/A | Net income $35.6m (FY, 2022) |
Funding | |||
Total funding raised | Total funding raised $ 102.8m | Total funding raised $ 17m | Total funding raised $ 12.3m |
For sources of this data, please see the company profile
View Company Profiles
Quellis Biosciences
HQ
Boston, US
Quellis is a biopharmaceutical company focused on discovering new molecules to treat serious rare diseases.
View companyEagle Pharmaceuticals
HQ
Woodcliff Lake, US
Employees
108↑ 13% increase
Eagle Pharmaceuticals is a specialty pharmaceutical company, focusing on developing and commercializing injectable products primarily in the critical care and oncology areas.
View company